126 related articles for article (PubMed ID: 19239400)
1. Pharmacokinetic profile of a new formulation of injection diclofenac designed for intradeltoid use.
Ojha A; Shep D; Nivsarkar M; Patel S; Jaiswal V; Padh H
Expert Opin Pharmacother; 2009 Mar; 10(4):517-22. PubMed ID: 19239400
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability study of a new formulation of injection of 75 mg diclofenac sodium in 1 ml with the conventional injection of 75 mg diclofenac sodium given in 3 ml volume.
Shep D; Ojha A; Patel S; Nivsarkar M; Jaiswal V; Padh H
Curr Clin Pharmacol; 2011 Feb; 6(1):26-9. PubMed ID: 21235465
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers.
Shep D; Ojha A; Patel S; Nivsarkar M; Jaiswal V; Padh H
J Pain Res; 2010 Nov; 3():235-40. PubMed ID: 21311716
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Shaw LM; Kang JS
Clin Ther; 2008 Apr; 30(4):633-40. PubMed ID: 18498912
[TBL] [Abstract][Full Text] [Related]
5. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.
Mukherjee J; Das A; Chakrabarty US; Sahoo B; Sengupta P; Chatterjee B; Roy B; Pal TK
Arzneimittelforschung; 2010; 60(8):506-9. PubMed ID: 20863007
[TBL] [Abstract][Full Text] [Related]
7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations.
Basmenji S; Valizadeh H; Zakeri-Milani P
Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Safety of a Diclofenac Sodium 75 mg/1 mL Solution (Akis
Leuratti C; Loprete L; Rossini M; Frangione V; Rovati S; Radicioni M
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):681-689. PubMed ID: 31077065
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of two different diclofenac formulations in healthy volunteers.
Silva LC; Simões IG; Lerner FE; Belém GR; de Moraes ME; De Nucci G
Arzneimittelforschung; 1999 Nov; 49(11):920-4. PubMed ID: 10604045
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of low-dose diclofenac potassium tablet formulations.
Hinz B; Hug AM; Fotopoulos G; Gold MS
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):643-8. PubMed ID: 19825328
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
15. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of a novel new injectable diclofenac formulation designed for intradeltoid use in post-operative pain management.
Shah P; Subnis B; Varshney A; Pradhan C; Murthy TV; Shah D; Jaiswal V
Int J Clin Pharmacol Ther; 2011 Apr; 49(4):286-90. PubMed ID: 21429443
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Bristaflam) in healthy human volunteers.
Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
Biopharm Drug Dispos; 2004 Apr; 25(3):103-8. PubMed ID: 15083498
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
[TBL] [Abstract][Full Text] [Related]
20. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
Hasan M; Otoom S; Najib N; Sallam el-S
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
